4//SEC Filing
Burrell Terry-Ann 4
Accession 0000899243-23-010815
CIK 0001745999other
Filed
Apr 4, 8:00 PM ET
Accepted
Apr 5, 8:30 PM ET
Size
7.1 KB
Accession
0000899243-23-010815
Insider Transaction Report
Form 4
Transactions
- Sale
Common Stock
2023-04-03$30.31/sh−2,454$74,381→ 49,303 total - Sale
Common Stock
2023-04-04$29.09/sh−2,186$63,598→ 47,117 total
Footnotes (3)
- [F1]These shares of common stock were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person prior to February 27, 2023.
- [F2]Includes 480 shares acquired by the Reporting Person under the Beam Therapeutics Inc. Amended and Restated 2019 Employee Stock Purchase Plan on March 31, 2023.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $28.79 to $29.10, inclusive. The Reporting Person undertakes to provide to Beam Therapeutics Inc. ("BEAM"), any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Documents
Issuer
Beam Therapeutics Inc.
CIK 0001745999
Entity typeother
Related Parties
1- filerCIK 0001786484
Filing Metadata
- Form type
- 4
- Filed
- Apr 4, 8:00 PM ET
- Accepted
- Apr 5, 8:30 PM ET
- Size
- 7.1 KB